Clinical Trial Update: Premedication for Less Invasive Surfactant Administration Study (PRELISA) [Phase 4]

View source ↗

Summary

The PRELISA trial evaluating premedication for less invasive surfactant administration in newborns with respiratory distress syndrome has completed Phase 4.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome of the Newborn

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Respiratory Distress Syndrome, Newborn | Phase 4 | Status: COMPLETED